SecProbe.io

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 September 4, 2025

David Yan
Chief Executive Officer
AlphaVest Acquisition Corp.
205 W. 37th Street
New York, NY 10018

 Re: AlphaVest Acquisition Corp.
 Preliminary Proxy Statement on Schedule 14A
 Filed August 21, 2025
 File No. 001-41574
Dear David Yan:

 We have reviewed your filing and have the following comment(s).

 Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

 After reviewing your response to this letter, we may have additional
comments.

Preliminary Proxy Statement on Schedule 14A
Risk Factors
Nasdaq may delist our securities from trading on its exchange, which could
limit investors'
ability..., page 39

1. We note that you are seeking to extend your termination date to January
22, 2026, a
 date which is 37 months from your initial public offering. We also note
that you are
 currently listed on Nasdaq and that Nasdaq Rule 5815 was amended
effective October
 7, 2024 to provide for the immediate suspension and delisting upon
issuance of a
 delisting determination letter for failure to meet the requirement in
Nasdaq Rule IM
 5101-2(b) to complete one or more business combinations within 36 months
of the
 date of effectiveness of its IPO registration statement. Please revise
to state that your
 securities will face immediate suspension and delisting action once you
receive a
 delisting determination letter from Nasdaq after the 36-month window
ends on
 December 22, 2025. Please disclose the risks of non-compliance with this
rule,
 including that under the new framework, Nasdaq may only reverse the
determination
 if it finds it made a factual error applying the applicable rule. In
addition, please also
 disclose the consequences of any such suspension or delisting, including
that your
 September 4, 2025
Page 2

 stock may be determined to be a penny stock and the consequences of that
 designation, that you may no longer be attractive as a merger partner if
you are no
 longer listed on an exchange, any potential impact on your ability to
complete an
 initial business combination, any impact on the market for your
securities including
 demand and overall liquidity for your securities, and any impact on
securities holders
 due to your securities no longer being considered covered securities.

 We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

 Please contact Kate Beukenkamp at 202-551-3861 or Donald Field at
202-551-3680
with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Trade &
Services
cc: Michael Blankenship
</TEXT>
</DOCUMENT>